Newsletter
June 2024
Think Horses First
Stroke
During 2011–2022, U.S. self-reported stroke prevalence remained highest among adults aged 65 and older and was stable. However, reported prevalence increased among adults aged 18–44 (15%) and 45–64 (16%). These increases correspond with a rise in cardiovascular risk factors among working-age adults in recent decades. Clinicians can address these risk factors through prevention and treatment. Clinicians can educate patients, including adults younger than 65, about the signs and symptoms of stroke and the need to call 9-1-1 immediately after stroke symptoms are observed.
Don’t Forget Zebras
Avian Influenza
As of May 24, 2024, CDC had confirmed two cases of highly pathogenic avian influenza A(H5N1) in dairy farm workers. Both workers had conjunctivitis only. The cases were linked to an ongoing outbreak among cows. Clinicians should consider A(H5N1) infection in patients with conjunctivitis or acute respiratory illness and recent potential novel influenza A virus exposures (e.g., agricultural fair attendance or contact with infected animals). Clinicians should contact their state or local health department to arrange for A(H5N1) testing. Patients with confirmed or suspected A(H5N1) infection should be treated with oseltamivir.
Opportunities to Improve Clinical Outcomes
Cigarette smoking among pregnant and postpartum women
Read more about cigarette smoking among pregnant and postpartum women
Hepatitis C clearance
Hepatitis C is a deadly, yet curable disease. Well-tolerated therapies can cure more than 95% of people with hepatitis C virus (HCV) infections. Among a national sample, 1,015,147 patients had a detectable HCV RNA test result during 2013–2022. Across all states, only 10%–51% of these patients received a subsequent undetectable result and were considered cured or cleared. CDC recommends hepatitis C screening for all adults at least once in their lifetime. Except for pregnant people and children younger than 3 years old, clinicians should treat patients with detectable HCV RNA with oral direct-acting antiviral agents.
Did you know? Medscape & MMWR have FREE CME activities
Continuing medical education credits are available from Medscape on select MMWRs.
Subscribe to our newsletter
Get our monthly newsletter delivered to your email inbox.